David Smadja 🎗️
davidmsmadja.bsky.social
Professeur d’Hématologie, Hôpital Europeen Georges Pompidou et Université Paris cité Inserm PARCC team director « endotheliopathy and Hemostasis disorders » Association Résiste de lutte contre le harcèlement scolaire et le cyber harcèlement
👤 Joined on 11 November 2024
198
Followers
97
Following
13
Total Posts
📜 Kullanıcı Geçmişi
- 11 Kas 2024, 14:48
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@davidmsmadja.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Management of Monoclonal Gammopathy of Undetermined Significance. In low-risk patients who are younger than 50 years of age, bone marrow biopsy and imaging may be considered a baseline evaluation, given the anticipated life expectancy. Learn more: nej.md/473uOsj #MedSky #Hematology
Show Post
🚨 New paper from the lab in ATVB Dexamethasone protects against COVID-19 endothelium-induced coagulopathy 🦠🔥🫁🩸 @davidmsmadja.bsky.social @hopitalpompidou.bsky.social @upcite.bsky.social @parcc-inserm.bsky.social @ahajournals.bsky.social @inserm.fr www.ahajournals.org/doi/10.1161/...
Show Post
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes go.nature.com/46paWQ0
Show Post
Maladie thromboembolique veineuse : prédire le risque de récidive grâce à la génétique Lire le communiqué : presse.inserm.fr/maladie-thro...
Show PostNew study in #Blood VTH: We show that the AcuStar HIT-IgG (Werfen) CLIA is a reliable & fast ⏱️ diagnostic tool for #HIT with strong agreement vs anti-PFA/H ELISA (Hyphen) & SRA @davidmsmadja.bsky.social @hopitalpompidou.bsky.social @bloodjournals.hematology.org ashpublications.org/bloodvth/art...
Show Post